Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q2 2018 · 10-Q
Revenue$1.00M$1.00M+56.7% vs Q2 2017 Net Income-$627.00K-$627.00KN/M vs Q2 2017 EPS Diluted-$7.66-$7.66N/M vs Q2 2017 Gross Profit$277,000+88.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,194,000N/M Free Cash Flowderived-$2,221,000N/M Margins · derivedGross margin27.6%+4.6 pt vs Q2 2017
Operating margin-146.9%+211.6 pt vs Q2 2017
Net margin-62.5%+295.9 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 6, 2018 · 37 d after period end